Cultural basis for differences between US and French clinical recommendations for women at increased risk of breast and ovarian cancer
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Two recent consensus statements, one from the USA 1 Burke W Daly M Garber J et al. Recommendations for follow-up care of individuals with an inherited predisposition to cancer—II BRCAI and BRCA2: Cancer Genetics Studies Consortium.. JAMA. 1997; 277: 997-1003 Crossref PubMed Google Scholar and one from France, 2 Eisinger F Alby N Bremond A et al. Recommendations for medical management of hereditary breast and ovarian cancer: the French National Ad Hoc Committee.. Ann Oncol. 1998; 9: 939-950 Crossref PubMed Scopus (126) Google Scholar made recommendations about clinical management of women with an inherited predisposition to breast cancer and ovarian cancer due primarily to the presence of BRCA1 or BRCA2 susceptibility-conferring alleles. The groups formulating these statements had the difficult task of making recommendations despite inadequate or equivocal evidence on risk reduction strategies. The two sets of recommendations are similar for the most part, but they diverge in some areas of clinical uncertainty (panel). We believe that the divergence in three areas—breast self-examination, lifestyle, and prophylactic surgery—partly reflects the cultural context in which physicians and patients make decisions and health policies are formulated. Tabled 1 Intervention USA1 Burke W Daly M Garber J et al. Recommendations for follow-up care of individuals with an inherited predisposition to cancer—II BRCAI and BRCA2: Cancer Genetics Studies Consortium.. JAMA. 1997; 277: 997-1003 Crossref PubMed Google Scholar France2 Eisinger F Alby N Bremond A et al. Recommendations for medical management of hereditary breast and ovarian cancer: the French National Ad Hoc Committee.. Ann Oncol. 1998; 9: 939-950 Crossref PubMed Scopus (126) Google Scholar Breast self-examination Recommended Not recommended (training on request) Breast examination by a physician Recommended, by age 25–35, once or twice a year Recommended by age 20, two to three times a year Mammography Suggested by age 25–35 Recommended by age 30 Clinical examination for ovarian cancer Not considered Recommended Ovarian cancer screening by ultrasonography Recommended Recommended Ovarian cancer screening with CA125 Recommended Research only Prostate cancer screening in male relative No position No position Colorectal cancer screening Same as in general population No position Prophylactic mastectomy Informed consent sufficient Informed consent insufficient Prophylactic oophorectomy Informed consent sufficient Informed consent insufficient Hormone replacement therapy No position No contraindication Hormonal contraception No position No contraindication Chemoprevention (tamoxifen) No position Research only Diet Counselling No position Tobacco Counselling No position Open table in a new tab
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Charles, C., Gafni, A., & Whelan, T. (1997) · Social Science & Medicine · doi:10.1016/s0277-9536(96)00221-3 · Cited by 4,137
Burke, W. (1997) · JAMA · doi:10.1001/jama.277.12.997 · Cited by 955
Self-citation
Cited by
Relationship between cancer patients' predictions of prognosis and their treatment preferences
Weeks, J. C. (1998) · JAMA · doi:10.1001/jama.279.21.1709 · Cited by 1,319
Grol, R. (2001) · JAMA · doi:10.1001/jama.286.20.2578 · Cited by 594
Effects of evidence-based clinical practice guidelines on quality of care: a systematic review
Lugtenberg, M., Burgers, J. S., & Westert, G. P. (2009) · Quality and Safety in Health Care · doi:10.1136/qshc.2008.028043 · Cited by 478
Burgers, J. S., Fervers, B., Haugh, M., Brouwers, M., Browman, G., Philip, T., & Cluzeau, F. A. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.06.157 · Cited by 463
Will Genetics Revolutionize Medicine?
Holtzman, N. A., & Marteau, T. M. (2000) · New England Journal of Medicine · doi:10.1056/nejm200007133430213 · Cited by 408
Self-citation
Metadata
- Authors
- Eisinger, F., Geller, G., Burke, W., & Holtzman, N.
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 1999-03
- Volume
- 353
- Issue
- 9156
- Pages
- 919-920
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W2088952832
- Cited by
- 128
- References
- 2
- FWCI
- 4.56
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cultural basis for differences between US and French clinical recommendations for women at increased risk of breast and ovarian cancer. https://app.cochat.ai/papers/10.1016/s0140-6736(98)07516-3
- The paper
- Eisinger, F., Geller, G., Burke, W., & Holtzman, N. (1999). Cultural basis for differences between US and French clinical recommendations for women at increased risk of breast and ovarian cancer. The Lancet. https://doi.org/10.1016/s0140-6736(98)07516-3
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.